Our aim is to discuss the role of high dose methylprednisolone therapy in children with acute transverse myelitis.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Acute transverse myelitis is an uncommon disease characterized by abrupt onset of progressive weakness and sensory disturbance in the lower extremities accompanied by bladder and bowel disfunction.
📊
Key Findings & Data:It's course is variable; 50 % of patients make a full recovery, 10 % have no recovery, and 40 % recover incompletely.
💡
Conclusion & Impact:Our aim is to discuss the role of high dose methylprednisolone therapy in children with acute transverse myelitis.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Acute transverse myelitis is an uncommon disease characterized by abrupt onset of progressive weakness and sensory disturbance in the lower extremities accompanied by bladder and bowel disfunction. It's course is variable; 50 % of patients make a full recovery, 10 % have no recovery, and 40 % recover incompletely. Steroids are used as a treatment model however, it's effect on the course or prognosis of acute transverse myelitis is controversial.In this study, four children with acute transverse myelitis are presented. Our aim is to discuss the role of high dose methylprednisolone therapy in children with acute transverse myelitis.
🔖
Cite This Article
AKDAĞ, A., ERGÜVEN, M., FEDAKAR, A., ÖCAL, S., EMEKSİZ, C., ALTUNYUVA, S. (2022). Influence of high dose methylprednisolone therapy on prognosis of acute transverse myelitis in children. Göztepe Tıp Dergisi, Cilt: 20 - Sayı: 3, 190–192. https://ajindex.com/articles/526441
Piccola G, Franciotta DM, Comona et al: Devic's neuromyelitis optica: long-term follow-up and serial CSF findings in two cases. J Neurol 237849:262-4, 1990
Dunne K, Hopkins IJ, Shield LK: Acute transverse myelopathy in childhood. Dev Med Child Neurol 98:198-204, 1986
Fonseca LF, Noce TR, Teixeira AL Jr et al: Early-onset acute transverse myelitis following hepatitis B vaccination and respiratory infection: case report. Arq Neuropsiquiatr. 2003 jun;61(2A):265-8. Equb 2003 jun 09
Nakamura N, Nokura K, Zettsu T, et al: Neurologic complicati¬ ons associated with influenza vaccination: two adult cases. Intern Med 42(2):191-4,2003
Straussberg R, Schanfield T, Wertz R et al: Improvement of aty- pical acute disseminated encephalomyelitis with steroids and intrave- nous immunoglobins. Pediatr neurol 24(2)139-43, 2001
RS Rust, R. Chun. D. De Vivo Presentation and outcome of childhood. Child Neurology Society, prog, and abst. 1993 p.78
Tola MR, Granieri E, Caniatti, et al: Systemic lupus erythema- tosus presenting with neurological disorders. J Neurol 239(2): 61-4, 1992
Miller JJ: Prolonged use of large intravenous pulses in the re- umatic diseases of children. Pediatrics 65:989-94, 1980
Silverman ED, Myones BLL, Miller JJ: Lymphocytes subpopu- lation alterations induced by intravenous megadose pulse methyl- prednisolone. J Rheumatol 11:287-90,1984
Sebire G, Delfraissy JF, Demotes-Mainard J, et al: Interleukin- 13 and interleukin-4 act as interleukin-6 inducers in human microglial cells. Cytokine 8:636-41, 1996
Lahat E, Pillar G, Ravid S, et al: Rapid recovery from transver- se myelopathy in children treated with methylprednisolone. Pediatr Neurol 19(4): 279-82, 1998
Harisdankui V, Doorenbos D, Subramay SH: Lupus transverse myelopathy: (better outcome with early recognition and agressive high-dose intravenous corticosteroid pulse treatment). J Neurol 242(5):326-31, 1995
Defresne P, Meyer L, Tardieu M, et al: Eficiancy of high dose steroid